MARTIN DROST: Open Payments
NPI 1235135351 · NORTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 49 payments from 18 companies in 2025. Trend: 2023 $1,059 · 2024 $1,370 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $200 |
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| ViiV Healthcare Company | 7 | $151 |
| Novo Nordisk Inc | 6 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Ardelyx, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
Products named: AIRSUPRA, APRETUDE, ELIQUIS, Wegovy, Kerendia, ZENPEP, PREVNAR 20, EOHILIA.
Industry payments across FL — which companies pay providers there.
